We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

124 hedge funds and large institutions have $440M invested in Immunomedics Inc in 2017 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 39 increasing their positions, 32 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 15

99% more capital invested

Capital invested by funds: $221M → $440M (+$219M)

86% more call options, than puts

Call options by funds: $21.2M | Put options by funds: $11.4M

22% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 32

14% more funds holding

Funds holding: 109 → 124 (+15)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
124
Holders Change
+15
Holders Change %
+13.76%
% of All Funds
3.09%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
36
Increased
39
Reduced
32
Closed
15
Calls
$21.2M
Puts
$11.4M
Net Calls
+$9.85M
Net Calls Change
+$622K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$40.1M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$23.2M
3
FCM
Farallon Capital Management
California
+$21M
4
RG
Redmile Group
California
+$17.1M
5
State Street
State Street
Massachusetts
+$9.64M

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$21.3M
2
O
OrbiMed
New York
-$13M
3
TCP
Tourbillon Capital Partners
New York
-$8.81M
4
Millennium Management
Millennium Management
New York
-$5.26M
5
JGC
J. Goldman & Co
New York
-$3.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
101
Raymond James Financial Services Advisors
Florida
$84K -$19.5K -3,849 -23%
BW
102
Biegel & Waller
Maryland
$84K – – –
AB
103
Amalgamated Bank
New York
$77K -$122 -24 -0.2%
SG Americas Securities
104
SG Americas Securities
New York
$67K -$155K -30,523 -75%
BW
105
Bison Wealth
Georgia
$65K – – –
AAP
106
Ardsley Advisory Partners
Connecticut
$65K +$50.7K +10,000 New
Royal Bank of Canada
107
Royal Bank of Canada
Ontario, Canada
$63K -$13.1K -2,587 -21%
LPL Financial
108
LPL Financial
California
$63K +$50.9K +10,050 New
ST
109
Spot Trading
Illinois
$48K +$37.3K +7,355 New
AIP
110
Ameritas Investment Partners
Nebraska
$44K +$34.5K +6,814 New
SSB
111
Sandy Spring Bank
Maryland
$41K +$5.07K +1,000 +19%
SPIA
112
Steward Partners Investment Advisory
New York
$25K +$20.3K +4,000 New
UBS Group
113
UBS Group
Switzerland
$24K +$5.07K +1,000 +37%
Zurich Cantonal Bank
114
Zurich Cantonal Bank
Switzerland
$22K – – –
SCM
115
Segantii Capital Management
Hong Kong
$22K +$17.2K +3,400 New
CG
116
Cutler Group
California
$16K +$9.52K +1,879 +261%
US Bancorp
117
US Bancorp
Minnesota
$13K +$10.1K +2,000 New
Nisa Investment Advisors
118
Nisa Investment Advisors
Missouri
$10K +$7.6K +1,500 New
AG
119
Advisor Group
Arizona
$7K – – –
SEI Investments
120
SEI Investments
Pennsylvania
$5K +$4.23K +835 New
BNP Paribas Financial Markets
121
BNP Paribas Financial Markets
France
$4.3K -$24.9K -4,917 -88%
MAM
122
Meeder Asset Management
Ohio
$3K -$1.32K -261 -38%
Bank of Montreal
123
Bank of Montreal
Ontario, Canada
$3K – – –
MPWT
124
MassMutual Private Wealth & Trust
Connecticut
$1.29K – – –
TCP
125
Tourbillon Capital Partners
New York
– -$8.81M -2,400,000 Closed
2 3 4
5
6

IMMU Hedge Fund Activity: Q1 2017 in Review

124 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2017, worth a combined $440M — up 99% from $221M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new IMMU positions and 15 closed out — a net gain of 21 holders — while 39 added to existing stakes and 32 trimmed.

The largest buyer was BlackRock, adding an estimated $40.1M. The largest seller was Acuta Capital Partners, cutting an estimated $21.3M.

  • 124 institutional investors held Immunomedics Inc (IMMU) as of Q1 2017, up from 109 in Q4 2016.
  • Funds reported $440M of Immunomedics Inc stock for Q1 2017, up 99% quarter-over-quarter.
  • 36 funds opened new Immunomedics Inc positions in Q1 2017 and 15 closed out, a net change of +21 holders.
  • The largest Immunomedics Inc buyer in Q1 2017 was BlackRock, an estimated $40.1M added.
  • The largest Immunomedics Inc seller in Q1 2017 was Acuta Capital Partners, an estimated $21.3M sold.

Based on aggregated 13F filings for Q1 2017.